metastatic castrate-resistant prostate cancer (mCRPC)

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

metastatic castrate-resistant prostate cancer (mCRPC)

Nov 18, 2024, 12:57 | Insight

Aruni Ghose: AKT + Androgen Receptor Signalling Inhibitors in the mCRPC

Aruni Ghose, Internal Medicine Resident at Barts Health NHS Trust, shared a post on LinkedIn: "Hot…

Oct 14, 2024, 15:14 | Drugs

Toni Choueiri: Talazoparib with or without enzalutamide in mCRPC

Toni Choueiri shared on X: ''JUST IN: HUGE NEWS ==> OS benefit from TALAPRO-2 study…

All: 2 Posts: 1 - 100

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023